MIM
GPCR icon

Monashee Investment Management’s Structure Therapeutics GPCR Stock Holding History

Monashee Investment Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Sell
50,000
-175,000
-78% -$12M 1.31% 26
2025
Q4 		$15.6M Buy
225,000
+25,000
+13% +$1.02M 8.82% 1
2025
Q3 		$5.6M Sell
200,000
-230,000
-53% -$4.58M 2.79% 12
2025
Q2 		$8.92M Buy
430,000
+137,138
+47% +$3.02M 3.23% 10
2025
Q1 		$5.07M Buy
292,862
+160,862
+122% +$3.94M 0.6% 25
2024
Q4 		$3.58M Sell
132,000
-27,608
-17% -$980K 0.49% 19
2024
Q3 		$7.01M Buy
159,608
+109,608
+219% +$4.24M 0.76% 17
2024
Q2 		$1.96M Sell
50,000
-44,714
-47% -$1.84M 0.25% 44
2024
Q1 		$4.06M Sell
94,714
-97,141
-51% -$4.1M 0.48% 36
2023
Q4 		$7.82M Sell
191,855
-441,911
-70% -$25.3M 1.38% 9
2023
Q3 		$32M Sell
633,766
-737,225
-54% -$23.8M 13.35% 1
2023
Q2 		$22.8M Buy
1,370,991
+1,200,991
+706% +$33.7M 5.43% 3
2023
Q1 		$4.04M Buy
+170,000
New +$3.99M 1.12% 19

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Monashee Investment Management's GPCR Position: Q1 2026 in Review

Monashee Investment Management reduced its Structure Therapeutics (GPCR) stake by 78% in Q1 2026, selling an estimated $12M and leaving 50,000 shares worth $2.41M. The position accounts for 1.31% of the portfolio, ranked #26.

Monashee Investment Management first reported a position in GPCR in Q1 2023 and has held it in 13 quarters since. The position peaked at $32M in Q3 2023. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Monashee Investment Management held 50,000 shares of Structure Therapeutics worth $2.41M as of Q1 2026.
  • Monashee Investment Management sold 175,000 Structure Therapeutics shares in Q1 2026, an estimated $12M.
  • Structure Therapeutics made up 1.31% of Monashee Investment Management's portfolio in Q1 2026, its #26 holding.
  • Monashee Investment Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Monashee Investment Management's Structure Therapeutics position peaked at $32M in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Monashee Investment Management's 13F filing for Q1 2026, filed 13 May 2026.